(Q27655356)

Alain R Baulard

17

0 references

Matthieu Desroses

Matthieu Desroses

6

0 references

Vincent Villeret

Vincent Villeret

15

0 references

Pablo Bifani

Pablo Bifani

4

0 references

Rébecca F Déprez-Poulain

Rebecca Déprez-Poulain

10

0 references

Benoit Deprez

Benoit Déprez

16

0 references

Camille Locht

Camille Locht

14

0 references

author name string

Nicolas Willand

1

0 references

Bertrand Dirié

2

0 references

Amit Singhal

5

0 references

Florence Leroux

7

0 references

Eve Willery

8

0 references

Vanessa Mathys

9

0 references

Guy Delcroix

11

0 references

Frédéric Frénois

12

0 references

Marc Aumercier

Characteristic physical properties and structural fragments of marketed oral drugs.

13

0 references

language of work or name

English

0 references

publication date

May 2009

0 references

published in

Nature Medicine

0 references

volume

15

0 references

issue

5

0 references

page(s)

537-44

0 references

cites work

1 reference

12 December 2020

Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3.

1 reference

12 December 2020

Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria

1 reference

12 December 2020

Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis

1 reference

12 December 2020

ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates

1 reference

12 December 2020

EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator

1 reference

12 December 2020

The absorption and toxicity of ethionamide

1 reference

12 December 2020

The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

1 reference

12 December 2020

Lead- and drug-like compounds: the rule-of-five revolution

1 reference

12 December 2020

Activation of the pro-drug ethionamide is regulated in mycobacteria

1 reference

12 December 2020

Structure of EthR in a ligand bound conformation reveals therapeutic perspectives against tuberculosis

1 reference

12 December 2020

Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

1 reference

12 December 2020

Crystal structure of the TetR/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance

1 reference

12 December 2020

Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis.

1 reference

12 December 2020

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

1 reference

12 December 2020

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

12 December 2020

Neurological manifestations and toxicities of the antituberculosis drugs. A review

1 reference

12 December 2020

ETHIONAMIDE AND ISONIAZID IN PREVIOUSLY UNTREATED CASES OF PULMONARY TUBERCULOSIS

1 reference

12 December 2020

Use of TLS parameters to model anisotropic displacements in macromolecular refinement

1 reference

12 December 2020

HIV infection and multidrug-resistant tuberculosis: the perfect storm

1 reference

12 December 2020

Molecular properties of WHO essential drugs and provisional biopharmaceutical classification

1 reference

12 December 2020

Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities

1 reference

12 December 2020

Molecular properties that influence the oral bioavailability of drug candidates

1 reference

12 December 2020

Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis

1 reference

12 December 2020

EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets

1 reference

12 December 2020

Population pharmacokinetics of ethionamide in patients with tuberculosis

1 reference

12 December 2020

Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides

1 reference

12 December 2020

The CCP4 suite: programs for protein crystallography

1 reference

12 December 2020

Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children

1 reference

12 December 2020

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

12 December 2020

A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy

1 reference

12 December 2020

Insights into mechanisms of induction and ligands recognition in the transcriptional repressor EthR from Mycobacterium tuberculosis

1 reference

12 December 2020

Coot: model-building tools for molecular graphics

1 reference

12 December 2020

Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis

1 reference

12 December 2020

Clinical pharmacokinetics of the antituberculosis drugs

1 reference

12 December 2020

Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.

1 reference

12 December 2020

1 reference

12 December 2020

Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance

1 reference

12 December 2020

Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.1950

7 January 2021